Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Ekaterina Obarevich"'
Autor:
N. S. Besova, Elena Artamonova, Kristina A. Novoselova, Vladimir Moiseyenko, Liubov Yu Vladimirova, Natalia Trenina, Margarita Suetina, Sergei Tjulandin, Ilya Tsimafeyeu, Vyacheslav Kurakin, Galina Statsenko, Mikhail Byakhov, Alina Kashanova, Ekaterina Obarevich, Natalia А. Abramova, Anastasia Mochalova
Publikováno v:
Cancer Research. 81:CT113-CT113
Fibroblast growth factor receptor 2 (FGFR2) is associated with an unfavorable prognosis in patients with gastric cancer. Acquired mutations in FGFR2 develop resistance to multikinase inhibitors. Besides, resistance to monoclonal antibodies depends on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0711d53050f023df438a0bce3f4c4db3
https://doi.org/10.1158/1538-7445.am2021-ct113
https://doi.org/10.1158/1538-7445.am2021-ct113
Autor:
Mikhail Davydov, Elena Trusilova, Ivan Stilidi, S N Nered, Natalia Sergeyevna Besova, Elena Artamonova, Tatiana Titova, Ekaterina Obarevich
Publikováno v:
Journal of Clinical Oncology. 38:363-363
363 Background: According to recent studies the results of treatment patients with initially mGC are still not sufficient: median overall survival varies between 6.1 and 12.4 months. The triplet-chemotherapy regimens demonstrate high efficacy and all
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e075b75c5c00cfd1badeee9a4fc3c73
https://doi.org/10.1200/jco.2020.38.4_suppl.363
https://doi.org/10.1200/jco.2020.38.4_suppl.363